Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 10-Feb-16 2:33 PM View:  | Clarus Lifesciences Ii, L.P. 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 09-Feb-16 | Market Sale | 230,507 | $0.16 | $36,881.10 | (9%) 2.45M to 2.21M | 6% |
| 10-Feb-16 2:33 PM View: | Clarus Lifesciences Ii, L.P. 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 08-Feb-16 | Market Sale | 103,123 | $0.19 | $19,593.40 | (4%) 2.55M to 2.45M | 22% |
| 05-Feb-16 8:39 PM View: | Clarus Lifesciences Ii, L.P. 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 05-Feb-16 | Market Sale | 832,881 | $0.20 | $166,576.00 | (25%) 3.38M to 2.55M | |
| 05-Feb-16 8:39 PM View: | Clarus Lifesciences Ii, L.P. 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 04-Feb-16 | Market Sale | 500,026 | $0.14 | $70,003.60 | (13%) 3.88M to 3.38M | 0% |
| 05-Feb-16 8:39 PM View: | Clarus Lifesciences Ii, L.P. 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 03-Feb-16 | Market Sale | 82,583 | $0.15 | $12,387.50 | (2%) 3.96M to 3.88M | 5% |
| 02-Feb-16 5:12 PM View: | Clarus Lifesciences Ii, L.P. 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 02-Feb-16 | Market Sale | 176,306 | $0.17 | $29,972.00 | (4%) 4.14M to 3.96M | |
| 02-Feb-16 5:12 PM View: | Clarus Lifesciences Ii, L.P. 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 01-Feb-16 | Market Sale | 140,000 | $0.20 | $28,000.00 | (3%) 4.28M to 4.14M | < 1% |
| 02-Feb-16 5:12 PM View: | Clarus Lifesciences Ii, L.P. 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 29-Jan-16 | Market Sale | 52,826 | $0.26 | $13,734.80 | (1%) 4.33M to 4.28M | 26% |
| 28-Jan-16 5:07 PM View: | Clarus Lifesciences Ii, L.P. 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 28-Jan-16 | Market Sale | 32,521 | $0.26 | $8,455.46 | (< 1%) 4.37M to 4.33M | 0% |
| 28-Jan-16 5:07 PM View: | Clarus Lifesciences Ii, L.P. 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 27-Jan-16 | Market Sale | 209,984 | $0.27 | $56,695.70 | (5%) 4.58M to 4.37M | 4% |
| 28-Jan-16 5:07 PM View: | Clarus Lifesciences Ii, L.P. 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 26-Jan-16 | Market Sale | 69,425 | $0.30 | $20,827.50 | (1%) 4.64M to 4.58M | 12% |
| 14-Jul-15 8:17 AM View: | Pecora Andrew L Director | TetraLogic Pharmaceuticals ... (TLOG) | 10-Jul-15 | Market Purchase | 50,000 | $2.68 | $133,944.00 | 37% 134.83K to 184.83K | 5% |
| 13-Jul-15 10:48 AM View: | Pecora Andrew L Director | TetraLogic Pharmaceuticals ... (TLOG) | 09-Jul-15 | Market Purchase | 50,000 | $2.40 | $120,090.00 | 59% 84.83K to 134.83K | 17% |
| 06-Jul-15 2:23 PM View: | Schmitt Paul J Director | TetraLogic Pharmaceuticals ... (TLOG) | 02-Jul-15 | Market Purchase | 10,000 | $2.34 | $23,356.90 | < 1% 1.53M to 1.54M | 4% |
| 31-Mar-15 7:03 AM View: | Meyers Peter A. CFO & Treasurer | TetraLogic Pharmaceuticals ... (TLOG) | 27-Mar-15 | Market Purchase | 5,000 | $4.35 | $21,750.00 | 3% 148.89K to 153.89K | 4% |
| 30-Mar-15 7:43 AM View: | Buchi J Kevin President & CEO Director | TetraLogic Pharmaceuticals ... (TLOG) | 26-Mar-15 | Market Purchase | 5,000 | $4.23 | $21,147.50 | 2% 325.71K to 330.71K | 7% |
| 09-Jan-15 7:00 AM View: | Buchi J Kevin President & CEO Director | TetraLogic Pharmaceuticals ... (TLOG) | 07-Jan-15 | Market Purchase | 5,000 | $5.04 | $25,181.00 | 2% 320.71K to 325.71K | 8% |
| 12-Dec-14 6:18 AM View: | Begley Colin Glenn Chief Scientific Officer & SVP | TetraLogic Pharmaceuticals ... (TLOG) | 10-Dec-14 | Market Purchase | 5,900 | $6.16 | $36,344.00 | 3% 192.23K to 198.13K | (1%) |
| 11-Dec-14 7:38 AM View: | Buchi J Kevin President & CEO Director | TetraLogic Pharmaceuticals ... (TLOG) | 09-Dec-14 | Market Purchase | 5,000 | $6.01 | $30,060.00 | 2% 315.71K to 320.71K | 3% |
| 08-Dec-14 7:29 AM View: | Meyers Peter A. CFO & Treasurer | TetraLogic Pharmaceuticals ... (TLOG) | 04-Dec-14 | Market Purchase | 1,034 | $4.94 | $5,107.96 | < 1% 147.86K to 148.89K | 20% |
| 04-Dec-14 7:30 AM View: | Buchi J Kevin President & CEO Director | TetraLogic Pharmaceuticals ... (TLOG) | 02-Dec-14 | Market Purchase | 10,000 | $4.99 | $49,900.00 | 3% 305.71K to 315.71K | (4%) |
| 01-Dec-14 11:47 AM View: | Begley Colin Glenn Chief Scientific Officer & SVP | TetraLogic Pharmaceuticals ... (TLOG) | 26-Nov-14 | Market Purchase | 1,100 | $4.87 | $5,351.94 | < 1% 192.23K to 193.33K | (< 1%) |
| 01-Dec-14 11:47 AM View: | Begley Colin Glenn Chief Scientific Officer & SVP | TetraLogic Pharmaceuticals ... (TLOG) | 26-Nov-14 | Market Purchase | 2,000 | $4.86 | $9,710.00 | 1% 190.23K to 192.23K | (< 1%) |
| 01-Dec-14 9:06 AM View: | Russell Lesley Chief Operating Officer | TetraLogic Pharmaceuticals ... (TLOG) | 26-Nov-14 | Market Purchase | 20,000 | $4.90 | $97,970.00 | 100% 0 to 20.0K | (1%) |
| 28-Nov-14 4:43 PM View: | Begley Colin Glenn Chief Scientific Officer & SVP | TetraLogic Pharmaceuticals ... (TLOG) | 25-Nov-14 | Market Purchase | 2,000 | $4.85 | $9,706.93 | 1% 188.23K to 190.23K | 1% |
| 20-Nov-14 8:31 AM View: | Buchi J Kevin President & CEO Director | TetraLogic Pharmaceuticals ... (TLOG) | 18-Nov-14 | Market Purchase | 10,000 | $4.82 | $48,185.00 | 3% 295.71K to 305.71K | < 1% |
| 19-Nov-14 12:36 PM View: | Pecora Andrew L Director | TetraLogic Pharmaceuticals ... (TLOG) | 17-Nov-14 | Market Purchase | 20,000 | $4.53 | $90,640.00 | 31% 64.83K to 84.83K | 2% |
| 13-Nov-14 10:00 PM View: | Meyers Peter A. CFO & Treasurer | TetraLogic Pharmaceuticals ... (TLOG) | 12-Nov-14 | Market Purchase | 5,000 | $3.98 | $19,890.00 | 4% 142.86K to 147.86K | 25% |
| 13-Nov-14 7:57 AM View: | Buchi J Kevin President and CEO Director | TetraLogic Pharmaceuticals ... (TLOG) | 11-Nov-14 | Market Purchase | 10,000 | $3.93 | $39,325.00 | 4% 285.71K to 295.71K | |
| 12-Nov-14 12:39 PM View: | Schmitt Paul J Director | TetraLogic Pharmaceuticals ... (TLOG) | 10-Nov-14 | Market Purchase | 10,000 | $4.14 | $41,352.00 | < 1% 1.52M to 1.53M | |
| 12-Nov-14 12:39 PM View: | Schmitt Paul J Director | TetraLogic Pharmaceuticals ... (TLOG) | 10-Nov-14 | Market Purchase | 10,000 | $4.06 | $40,630.00 | < 1% 1.51M to 1.52M | |
| 19-Dec-13 12:52 PM View: | Schmitt Paul J Director | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Conversion | 1,062,480 | $1.28 | $1,357,040.00 | 100% 0 to 1.06M | |
| 19-Dec-13 12:47 PM View: | Reed Douglas Md Director | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Purchase Duplicate | 142,857 | $7.00 | $999,999.00 | 13% 1.06M to 1.2M | |
| 19-Dec-13 2:29 PM View: | Woody James N. Director | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Purchase | 261,427 | $7.00 | $1,829,990.00 | 10% 2.74M to 3.0M | |
| 19-Dec-13 12:48 PM View: | Gavin Brenda D Director | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Conversion | 48,183 | $7.00 | $337,281.00 | 5% 900.09K to 948.27K | |
| 17-Dec-13 6:59 PM View: | Healthcare Ventures Vii Lp 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Conversion | 1,873,000 | $1.02 | $1,919,710.00 | 100% 0 to 1.87M | |
| 18-Dec-13 6:09 PM View: | Amgen Inc 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Conversion | 448,767 | -- | -- | 100% 0 to 448.77K | |
| 19-Dec-13 12:51 PM View: | Pecora Andrew L Director | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Purchase | 26,551 | $7.00 | $185,857.00 | 70% 38.12K to 64.67K | |
| 18-Dec-13 6:09 PM View: | Amgen Inc 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Exercise (in-the money or at-the-money) | 1,141 | $6.40 | $7,304.91 | < 1% 989.02K to 990.17K | |
| 19-Dec-13 12:49 PM View: | Clarus Lifesciences Ii, L.P. 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Purchase | 1,425,060 | $7.00 | $9,975,440.00 | 45% 3.2M to 4.62M | |
| 19-Dec-13 12:52 PM View: | Buchi J Kevin President and CEO Director | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Purchase | 285,714 | $7.00 | $2,000,000.00 | 100% 0 to 285.71K | |
| 19-Dec-13 12:49 PM View: | Clarus Lifesciences Ii, L.P. 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Exercise (in-the money or at-the-money) | 23,282 | $6.40 | $149,056.00 | < 1% 4.62M to 4.64M | |
| 19-Dec-13 12:52 PM View: | Schmitt Paul J Director | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Purchase | 445,179 | $7.00 | $3,116,250.00 | 42% 1.06M to 1.51M | |
| 19-Dec-13 12:47 PM View: | Reed Douglas Md Director | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Exercise (in-the money or at-the-money) | 7,590 | $6.40 | $48,592.70 | < 1% 1.2M to 1.21M | |
| 19-Dec-13 2:29 PM View: | Woody James N. Director | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Exercise (in-the money or at-the-money) | 3,064 | $6.40 | $19,616.30 | < 1% 3.0M to 3.01M | |
| 17-Dec-13 6:59 PM View: | Healthcare Ventures Vii Lp 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Purchase | 713,463 | $7.00 | $4,994,240.00 | 38% 1.87M to 2.59M | |
| 18-Dec-13 6:09 PM View: | Amgen Inc 10% Owner | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Conversion | 268,116 | -- | -- | 60% 448.77K to 716.88K | |
| 19-Dec-13 12:51 PM View: | Pecora Andrew L Director | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Exercise (in-the money or at-the-money) | 161 | $6.40 | $1,030.75 | < 1% 64.67K to 64.83K | |
| 19-Dec-13 12:47 PM View: | Reed Douglas Md Director | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Conversion | 1,059,300 | $1.84 | $1,948,200.00 | 100% 0 to 1.06M | |
| 19-Dec-13 2:29 PM View: | Woody James N. Director | TetraLogic Pharmaceuticals ... (TLOG) | 17-Dec-13 | Conversion | 737,497 | $1.06 | $783,475.00 | 37% 2.0M to 2.74M |
